Mary E LaMarca

Title: Mary E LaMarca: Innovator in Glucocerebrosidase Research

Introduction

Mary E LaMarca is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of treatments for Gaucher's disease. With a total of 2 patents, her work has had a profound impact on medical science.

Latest Patents

Mary E LaMarca's latest patents focus on the synthesis of unique glucocerebrosidase. The first patent discloses a method for producing glucocerebrosidase through recombinant methods, which is essential for treating Gaucher's disease. This patent includes a cDNA for encoding the specific protein and outlines the method of preparing the construct used to produce the protein. The second patent presents a pharmaceutical composition that comprises a therapeutic amount of glycosylated recombinantly-produced human glucocerebrosidase protein in a pharmaceutically acceptable carrier. This invention also details a method for treating Gaucher's disease by administering this composition to affected individuals.

Career Highlights

Mary E LaMarca works for the United States of America as represented by the Department of Health. Her role in this esteemed organization has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Throughout her career, Mary has collaborated with notable colleagues, including Kara A Maysak and Brian M Martin. These partnerships have fostered innovation and enhanced the development of her groundbreaking work.

Conclusion

Mary E LaMarca is a distinguished inventor whose research in glucocerebrosidase has paved the way for new treatments for Gaucher's disease. Her contributions to biotechnology continue to inspire advancements in medical science.